| Name | Title | Contact Details |
|---|
Founded in 1934, Beekley Corporation has evolved into the world leading supplier of simple innovative medical products that help imaging, surgical, and radiation therapy professionals save time, improve accuracy, enhance communication and provide a better patient experience. Beekley introduced the X-SPOT, the first ever professional skin marker for diagnostic imaging in 1984. The X-SPOT® replaced a variety of makeshift methods used at the time for communicating an area of concern on film. It quickly became a staple in radiology departments across the country and its quick adaptation in all radiology modalities led Beekley to devote itself to the research and development of simple, low cost, disposable products that would help imaging professionals improve communication, productivity, and patient care. Today, Beekley`s product line has grown to include a broad range of radiologic skin markers, biopsy and patient care devices for Mammography; Breast Biopsy; Radiation Therapy; MRI; CT-Scan and General Radiology.
At Proof, we believe that knowledge is power—and good health is a necessity. We`re a health technology and diagnostics company that is currently developing a cutting-edge, CRISPR-based platform for point-of-care facilities to test for COVID-19, with ambitions to transform in-home diagnostics across a broad spectrum of health applications in the future. Proof is the brainchild of Professor Feng Zhang, a world-renowned molecular biologist and leader of a research lab at the Broad Institute of MIT and Harvard. In early 2020, Dr. Zhang along with Dr. Jonathan Gootenberg and Dr. Omar Abudayyeh of the McGovern Institute pivoted their focus towards combating the emergent threat of the COVID-19 pandemic. Pioneers of the CRISPR gene-editing technology, the three scientists dropped everything to face the global public health crisis head on. Combining CRISPR and RT-LAMP technologies in a novel approach, our scientific team is developing a simple, streamlined molecular diagnostics platform that can quickly test for the presence of the SARS-CoV-2 virus. Intended for use within clinics, pharmacies, schools, workplaces and eventually homes, our easy-to-use, lab-quality test platform is undergoing rigorous R&D protocols so that we can provide fast, accurate diagnostics that will help communities take control of their health. We want to transform the anxiety of waiting days for COVID-19 test results into the peace of mind of quickly knowing what steps to take next. Our first test system, which we`re designing to detect SARS-CoV-2, will enable us to fulfill our mission of helping restore a degree of normalcy to our world. From there, we aim to transform personalized health, and expand our diagnostic platform to detect other diseases, with the goal of providing actionable health information that will allow people to lead better, healthier lives. If you`re with us, reach out today.
Antares Pharma is a revenue-generating product focused specialty pharmaceutical company that has developed three proprietary platforms, two of which now include FDA approved products. Our products typically improve safety and efficacy profiles by minimizing dosing and reducing side effects while improving patient compliance. We focus on self-injection pharmaceutical products and technologies and topical gel -based products. Our subcutaneous injection technology platforms include Vibex™ disposable pressure-assisted auto injectors, Vision® reusable needle-free injectors, and disposable multi-use pen injectors.
Healthline Medical is a Baldwin Park, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Howard Medical is a Ellisville, MS-based company in the Healthcare, Pharmaceuticals, and Biotech sector.